Litcius/Paper detail

Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials

Degu Jerene, Kristian van Kalmthout, Jens Levy, Jason Alacapa, Natasha Deyanova, Tanyaradzwa Dube, Andrew Mganga, Bianca Gonçalves Tasca, Alexsey Bogdanov, Egwuma Efo, Katya Gamazina, Anna Marie Celina Garfin, Volodymyr Kochanov, Adrian Leung, Norma Madden, Noriah Maraba, Christopher Finn McQuaid, Liberate Mleoh, Baraka Onjare, Rachel Powers, Yana Terleiva, Job van Rest, Agnes Gebhard, Katherine Fielding, Salome Charalambous

2025The Lancet16 citationsDOI

Topics & Concepts

TuberculosisMedicineCluster (spacecraft)DrugMedication adherenceDirectly Observed TherapyCluster randomised controlled trialDrug trialClinical trialTb treatmentMEDLINEIntensive care medicineInternal medicineRandomized controlled trialPharmacologyComputer sciencePathologyPolitical scienceProgramming languageLawMobile Health and mHealth ApplicationsTuberculosis Research and EpidemiologyPharmaceutical Quality and Counterfeiting
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials | Litcius